05 Compliance

The regulatory file for serratiopeptidase

Technical document 05 · Reviewed 2026-11-19 · Serratiopeptidase

On this page
  1. Four questions before the route
  2. European Union
  3. United States
  4. Contaminants against the ceiling
  5. What the label may say
  6. The file a brand should hold
  7. Checklist before the first shipment

Serratiopeptidase is a protein with a history of medicinal use in some markets, which makes the food-supplement route a market-by-market question rather than a property of the name. The catalog specification and the batch certificate describe the preparation; the buyer's regulatory team confirms the route, the permitted use and the label for the destination. This page sets out the framework, the limits and the documents that belong in that file.

In one line

The specification describes a preparation; the regulatory file has to show that the same preparation is allowed in the destination, and serratiopeptidase does not have one uniform route.

Four questions before the route

A complete file answers four things. Is the preparation allowed in the destination, and under which regime? Does the specification match the preparation that was assessed? Do the contaminants sit under the ceiling for the finished dose? And what may the label and the claim say? The certificate answers none of these on its own.

The first question is the hard one for this enzyme. In some markets serratiopeptidase has been authorised as a medicinal product, so a food or supplement route is a separate legal question and is not created by the name of the substance. A supplier statement that the material is “food grade” describes a specification, not a permission.

The second question is preparation-specific. Activity per gram, source strain, carrier, residual fermentation medium and intended use all describe the article that was assessed. A permission or an opinion about one preparation does not automatically cover a higher-activity powder, a granulated form or a blend.

Great Britain and Northern Ireland are checked separately. Great Britain applies a retained framework, with its own novel-food register and food-supplement rules; Northern Ireland follows the EU framework. The destination within the United Kingdom decides which file applies.

European Union

Four instruments frame the EU file. Regulation (EC) No 178/2002 sets the general food-law duties. Directive 2002/46/EC governs food supplements. Regulation (EU) 2015/2283 governs novel foods. Regulation (EC) No 1332/2008 applies where the enzyme is used for a technological function rather than as a nutritional ingredient, because a food enzyme needs to be covered by the Union list.

Serratiopeptidase has been examined under the novel-food framework, and national authorities have taken differing views on food-supplement sales. As of this review, the Union register and the destination member state's position are the references to check, and the buyer should not rely on a general statement that the ingredient is “EU approved”. The route may also depend on the preparation and on the food category.

Labelling follows Regulation (EU) No 1169/2011 and the supplement rules: the ingredient name, the carrier, the allergen statement where the source or the fermentation medium requires one, and the activity if it is declared. The EU regulatory note collects the framework references.

United States

The United States has no premarket approval list for a dietary ingredient. The route is DSHEA: a history of use before 15 October 1994, a new dietary ingredient notification at least 75 days before marketing, or a GRAS conclusion for the preparation and the use. A GRAS conclusion is company- and use-specific and does not travel with the name. The seller should be able to name the basis it relies on; the buyer confirms that the basis covers the finished product.

The finished supplement is made under 21 CFR 111 and labelled under 21 CFR 101. An enzyme activity has no Daily Value, so it is a quality characteristic rather than a nutrient amount; the label names the ingredient and the unit, and the certificate proves the figure. A structure/function statement needs substantiation and the DSHEA disclaimer, and a disease-related claim is not permitted.

No federal maximum applies to lead, cadmium or mercury in supplements. California Proposition 65 sets warning thresholds, and USP <2232> is a reference some buyers require. The catalog limits are release gates, not a federal ceiling. The US regulatory note gives the framework references.

Contaminants against the ceiling

The contaminant panel is a finished-product calculation as well as a drum result. The daily dose, the serving size and the destination text decide the ceiling that applies to the powder.

Heavy metals · catalog limits and regulatory references
MetalCatalog limitEU supplement referenceUS federal
Lead (Pb)≤3 mg/kg3.0 mg/kgNo maximum
Arsenic (As)≤2 mg/kgNo harmonised limitNo maximum
Cadmium (Cd)≤1 mg/kg1.0 mg/kgNo maximum
Mercury (Hg)≤0.1 mg/kg0.10 mg/kgNo maximum

The EU ceilings come from Regulation (EU) 2023/915; Great Britain retains Regulation (EC) No 1881/2006. Compare on the same basis: a result per kilogram of powder and a limit per daily dose are different calculations. Microbiology follows the catalog lines: APC ≤1,000 cfu/g, yeast and mould ≤100 cfu/g, and E. coli and Salmonella absent. The COA page shows where each result belongs on the certificate.

What the label may say

An enzyme activity is not a disease-related claim and must not be presented as one. The number of units describes the preparation; it does not describe an effect on the body. Wording that implies an effect on a disease or a clinical outcome is outside the file, whatever the certificate says.

In the EU, only authorised health claims may be used, and the register is checked for the exact wording. In the United States, a structure/function statement needs evidence and the DSHEA disclaimer. The label should use the ingredient name, the source and the activity with its unit, and it should match the specification that the market file covers.

The file a brand should hold

  • Specification naming the source, the strain, the activity, the method and unit definition, the carrier and the limits.
  • Batch COA with the activity result, the method, the loss on drying, the metals and the microbiology.
  • Technical data sheet and safety data sheet, both carrying the activity and the source.
  • Route memo for the destination: the regime, the preparation assessed and the permitted use.
  • Allergen, GMO, origin, carrier and residual-solvent statements.
  • Contaminant results with methods, converted to the finished dose.
  • Stability summary for the pack, plus the storage statement and the retest period.
  • Approved label artwork and the claim substantiation file.
  • Change-control record for source, process, carrier or pack.

Checklist before the first shipment

  1. Is the preparation named by source, strain, activity and carrier, not only by “serratiopeptidase”?
  2. Has the destination route been confirmed in writing, with the register or the notification cited?
  3. Is the activity reported with the method, the conditions and the unit definition?
  4. Do the metal results meet the destination's ceiling on the finished-dose basis?
  5. Are the allergen, carrier and GMO statements in the file?
  6. Does the label match the preparation and the rules of the destination?
  7. Is every claim authorised, or absent?
  8. Do the lot codes match on the COA, the pack and the packing list?

The product hub carries the catalog specification; the identity page covers the analytical evidence; the stability page covers the storage case; the quality page describes the release file. The UK regulatory note covers the retained framework.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation